Premium
CLOFAZIMINE (LAMPRENE) IN THE TREATMENT OF DISCOID LUPUS ERYTHEMATOSUS
Author(s) -
Krivanek J.,
Paver W. K. A.,
Kossard S.,
Cains G.
Publication year - 1976
Publication title -
australasian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.67
H-Index - 53
eISSN - 1440-0960
pISSN - 0004-8380
DOI - 10.1111/j.1440-0960.1976.tb00801.x
Subject(s) - clofazimine , medicine , discoid lupus erythematosus , lupus erythematosus , dermatology , systemic lupus erythematosus , surgery , leprosy , immunology , disease , antibody
S ummary Clofazimine was administered, over a period of six months, in a dose of 100 mgm per day, to nine patients with discoid lupus erythematosus. There was complete suppression or improvement in every patient but this took up to three months to become evident. The main side effect was a pleasing suntan colour of the skin.